Enzon Pharmaceuticals, Inc. (BST:EZ1)

Market Cap	4.71M
Revenue (ttm)	n/a
Net Income (ttm)	-2.22M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20
Average Volume	2,914
Open	0.0550
Previous Close	0.0555
Day's Range	0.0550 - 0.0555
52-Week Range	0.0485 - 0.2300
Beta	n/a
RSI	45.41
Earnings Date	Nov 14, 2025

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: EZ1

Financial Performance

Financial numbers in USD